Bingham’s comments carry significant weight because she reports directly to Prime Minister Boris Johnson and is plugged in to pharmaceutical companies around the globe.
Writing in The Lancet medical journal, Bingham said the most advanced options, including the much-hyped vaccine being developed in the United Kingdom by the University of Oxford and pharmaceutical giant AstraZeneca, are based on novel formats “for which we have little experience of their use”.
However, she did note promising early signs about their effectiveness and safety, and said governments around the world would have a…
